Neoleukin Therapeutics Inc.

(NLTX) Trade

By |

Profile

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. It generates immunotherapies using de novo protein design technology. The firm uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises of NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding.

Contact Information

Website: www.neoleukin.com
Email: investors@neoleukin.com
Main Phone: +1 206 732-2133
Address: 360-1616 Eastlake Avenue East
State: WA
City / Town: Seattle
Country: US
Postal Code: 98102

Issuer Information

Exchange: NSD
CEO: Jonathan G. Drachman
Employees: 65
NAICS: Pharmacies and Drug Stores(446110)

Equities News

Profile

Neoleukin Therapeutics Inc operates as a biopharmaceutical company. It generates immunotherapies using de novo protein design technology. The firm uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises of NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding.

Contact Information

Website: www.neoleukin.com
Email: investors@neoleukin.com
Main Phone: +1 206 732-2133
Address: 360-1616 Eastlake Avenue East
State: WA
City / Town: Seattle
Country: US
Postal Code: 98102

Issuer Information

Exchange: NSD
CEO: Jonathan G. Drachman
Employees: 65
NAICS: Pharmacies and Drug Stores(446110)

Equities News

$ 11.71 $ -0.17 (-1.43%)
Last Price 11.71 Change $ -0.17 Change % -1.43 Tick N/A
Bid 11.11 Bid Size 100.00 Ask 11.77 Ask Size 100.00
Open 11.80 High 12.21 Low 11.70 Prev Close 11.88
Last Trade Volume 166,240 52 Wk Hi 18.13 52 Wk Low 5.81
Market Cap 491.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,934,796.00 EPS (TTM) -0.48 PE Ratio -25.70 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 1
Number of Buys 1 1
Number of Sells 0 0
Net Activity 334428 334428
Last 10 Buys Shares
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
Daniel J. Levitt 1,000
Lloyd Mackenzie 1,000
David J. Main 1,000
David J. Main 1,000
David J. Main 1,000
Lloyd Mackenzie 1,000
Kamran Alam 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/28/18 06/28/18 06/28/18 06/28/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3